NASDAQ · WGS
GeneDx Holdings Corp.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for WGS: Nov 09, 2026
GeneDx Holdings Corp. Class A Common Stock is expected to report earnings on 11/09/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0.07. The reported EPS for the same quarter last year was $0.49.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.07 | $0.07 | $0.07 | 1 |
| Dec 2026 | $0.31 | $0.31 | $0.31 | 1 |
| Mar 2027 | $0.10 | $0.10 | $0.10 | 1 |
| Jun 2027 | $0.25 | $0.25 | $0.25 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · Zacks · RTTNews · The Motley Fool- BNK Invest · Oct 23, 3:34 PM EDTNoteworthy Friday Option Activity: AVGO, DELL, WGSAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Broadcom Inc (Symbol: AVGO), where a total of 235,613 contracts have traded so far, representing approximately 23.6 million underlying shares. That amounts to about 108.
- Zacks · Oct 8, 10:47 AM EDTTeladoc Strengthens Solo Platform With New AI-Powered Care ToolsTDOC expands Solo with AI tools that streamline virtual assessments and clinical documentation, targeting simpler workflows for hospitals.
- Zacks · Oct 7, 11:08 AM EDTEncompass Health Expands Rehab Footprint With New Maine HospitalEHC opens a 50-bed Maine rehab hospital, expanding its footprint as strong discharge growth and planned openings support capacity expansion.
- Zacks · Sep 8, 12:46 PM EDT3 Promising Genomics Stocks in the Spotlight in 2026Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.
- Zacks · Aug 24, 3:07 PM EDTTop Stock Picks for Week of August 24, 2026A Semiconductor Packaging Company with Strong Financial Momentum and a Medical Services Company with Solid Short-Term Price Momentum.
- RTTNews · Aug 24, 10:07 AM EDTGeneDx Study Supports Hospital-Wide Adoption Of Rapid Genome Sequencing In Pediatric Care(RTTNews) – GeneDx (WGS), a genomics company focused on rare disease diagnosis, announced new data published in Genetics in Medicine from a collaboration with Seattle Children's supporting broader use of rapid genome sequencing (rGS) across inpatient pediatric care.
- Zacks · Aug 19, 12:20 PM EDTCan GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?GeneDx Holdings Corp. (WGS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- The Motley Fool · Aug 10, 9:46 PM EDTGeneDx (WGS) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 3, 7:03 PM EDTGeneDx Q2 Earnings Call HighlightsFrom Industry Titans to Tiny Fish: 3 Key Stocks Insiders are TradingGeneDx (NASDAQ:WGS) reported second-quarter revenue of $114.4 million, above its prior guidance, as exome and genome testing volume reached a quarterly record of more than 30,000 tests. The company also returned
- Zacks · Aug 3, 5:45 PM EDTGeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass EstimatesGENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +105.26% and +4.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 16, 8:27 AM EDTPediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock?Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- The Motley Fool · Jun 23, 6:08 PM EDTWhat a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%The CFO of GeneDx reported selling 3,729 Class A shares for a total transaction value of $226,596.87 on June 16, 2026.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for GeneDx Holdings Corp. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.